Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

Turine, G, Peeters, Anna, Hermans, C, Eeckhoudt, S and Duprez, T 2017, Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer, Acta Neurologica Belgica, vol. 117, no. 3, pp. 753-755, doi: 10.1007/s13760-017-0751-5.


Title Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer
Author(s) Turine, G
Peeters, AnnaORCID iD for Peeters, Anna orcid.org/0000-0003-4340-9132
Hermans, C
Eeckhoudt, S
Duprez, T
Journal name Acta Neurologica Belgica
Volume number 117
Issue number 3
Start page 753
End page 755
Total pages 3
Publisher Springer
Place of publication Heidelberg, Germany
Publication date 2017-09-01
ISSN 0300-9009
2240-2993
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Clinical Neurology
Neurosciences
Neurosciences & Neurology
Ischemic stroke
Intravenous thrombolysis
Dabigatran
Idarucizumab
Language eng
DOI 10.1007/s13760-017-0751-5
Indigenous content off
Field of Research 1103 Clinical Sciences
1109 Neurosciences
HERDC Research category C4 Letter or note
Copyright notice ©2017, Belgian Neurological Society
Persistent URL http://hdl.handle.net/10536/DRO/DU:30121653

Document type: Journal Article
Collections: Faculty of Health
PVC's Office - Health
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 10 times in TR Web of Science
Scopus Citation Count Cited 12 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 69 Abstract Views  -  Detailed Statistics
Created: Fri, 17 May 2019, 10:07:31 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.